베이스 편집 시장(2025-2029년)

The global base editing market is forecasted to grow by USD 358.8 mn during 2024-2029, accelerating at a CAGR of 15.4% during the forecast period. The report on the global base editing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of genetic disorders and unmet medical needs, technological advancements enhancing precision and safety, rising investment and strategic collaborations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global base editing market is segmented as below:

By Type

• DNA base editing
• RNA base editing

By Application

• Drug discovery and development
• Agriculture
• Veterinary

By End-User

• Academic and research institutes
• Contract research organizations
• Pharmaceutical and biotechnology

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shift toward in vivo therapies and non-viral delivery systems as one of the prime reasons driving the global base editing market growth during the next few years. Also, expansion of therapeutic scope beyond monogenic diseases and integration of artificial intelligence and machine learning in editor design will lead to sizable demand in the market.

The report on the global base editing market covers the following areas:

• Global base editing market sizing
• Global base editing market forecast
• Global base editing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global base editing market vendors that include Beam Therapeutics Inc., Bio Palette Co., Ltd., Cellectis, Creative Biogene, Danaher Corp., EdiGene Inc., ElevateBio, Genkore, GenScript Biotech Corp., Intellia Therapeutics Inc., KROMATID, Maravai LifeSciences Holdings Inc., Merck KGaA, Pairwise, PerkinElmer US LLC, Qi Biodesign Technology, ShapeTX. Also, the global base editing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

• 5.1 Global Base Editing Market 2019 - 2023
  • Historic Market Size - Data Table on Global Base Editing Market 2019 - 2023 ($ million)
• 5.2 Type segment analysis 2019 - 2023
  • Historic Market Size - Type Segment 2019 - 2023 ($ million)
• 5.3 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.4 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in the global base editing market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 DNA base editing - Market size and forecast 2024-2029
• 8.4 RNA base editing - Market size and forecast 2024-2029
• 8.5 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Drug discovery and development - Market size and forecast 2024-2029
• 9.4 Agriculture - Market size and forecast 2024-2029
• 9.5 Veterinary - Market size and forecast 2024-2029
• 9.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Academic and research institutes - Market size and forecast 2024-2029
• 10.4 Contract research organizations - Market size and forecast 2024-2029
• 10.5 Pharmaceutical and biotechnology - Market size and forecast 2024-2029
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • 12.3.1 US - Market size and forecast 2024-2029
  • 12.3.2 Canada - Market size and forecast 2024-2029
  • 12.3.3 Mexico - Market size and forecast 2024-2029
• 12.4 Europe - Market size and forecast 2024-2029
  • 12.4.1 Germany - Market size and forecast 2024-2029
  • 12.4.2 UK - Market size and forecast 2024-2029
  • 12.4.3 France - Market size and forecast 2024-2029
  • 12.4.4 Italy - Market size and forecast 2024-2029
  • 12.4.5 The Netherlands - Market size and forecast 2024-2029
  • 12.4.6 Spain - Market size and forecast 2024-2029
  • 12.4.7 Russia - Market size and forecast 2024-2029
• 12.5 Asia - Market size and forecast 2024-2029
  • 12.5.1 China - Market size and forecast 2024-2029
  • 12.5.2 Japan - Market size and forecast 2024-2029
  • 12.5.3 India - Market size and forecast 2024-2029
  • 12.5.4 South Korea - Market size and forecast 2024-2029
  • 12.5.5 Indonesia - Market size and forecast 2024-2029
  • 12.5.6 Thailand - Market size and forecast 2024-2029
  • 12.5.7 Singapore - Market size and forecast 2024-2029
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • 12.6.1 Australia - Market size and forecast 2024-2029
  • 12.6.2 UAE - Market size and forecast 2024-2029
  • 12.6.3 Brazil - Market size and forecast 2024-2029
  • 12.6.4 South Africa - Market size and forecast 2024-2029
  • 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
  • 12.6.6 Turkey - Market size and forecast 2024-2029
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing prevalence of genetic disorders and unmet medical needs
  • Technological advancements enhancing precision and safety
  • Rising investment and strategic collaborations
• 13.2 Market challenges
  • Off-target effects and long-term safety concerns
  • Complexities and high cost of manufacturing and delivery
  • Stringent regulatory hurdles and uncertain reimbursement landscape
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities
  • Shift toward in vivo therapies and non-viral delivery systems
  • Expansion of therapeutic scope beyond monogenic diseases
  • Integration of artificial intelligence and machine learning in editor design

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Beam Therapeutics Inc.
  • Beam Therapeutics Inc. - Overview
  • Beam Therapeutics Inc. - Product / Service
  • Beam Therapeutics Inc. - Key offerings
  • SWOT
• 15.5 Bio Palette Co., Ltd.
  • Bio Palette Co., Ltd. - Overview
  • Bio Palette Co., Ltd. - Product / Service
  • Bio Palette Co., Ltd. - Key offerings
  • SWOT
• 15.6 Cellectis
  • Cellectis - Overview
  • Cellectis - Product / Service
  • Cellectis - Key offerings
  • SWOT
• 15.7 Creative Biogene
  • Creative Biogene - Overview
  • Creative Biogene - Product / Service
  • Creative Biogene - Key offerings
  • SWOT
• 15.8 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
  • SWOT
• 15.9 EdiGene Inc.
  • EdiGene Inc. - Overview
  • EdiGene Inc. - Product / Service
  • EdiGene Inc. - Key offerings
  • SWOT
• 15.10 ElevateBio
  • ElevateBio - Overview
  • ElevateBio - Product / Service
  • ElevateBio - Key offerings
  • SWOT
• 15.11 Genkore
  • Genkore - Overview
  • Genkore - Product / Service
  • Genkore - Key offerings
  • SWOT
• 15.12 GenScript Biotech Corp.
  • GenScript Biotech Corp. - Overview
  • GenScript Biotech Corp. - Business segments
  • GenScript Biotech Corp. - Key news
  • GenScript Biotech Corp. - Key offerings
  • GenScript Biotech Corp. - Segment focus
  • SWOT
• 15.13 Intellia Therapeutics Inc.
  • Intellia Therapeutics Inc. - Overview
  • Intellia Therapeutics Inc. - Product / Service
  • Intellia Therapeutics Inc. - Key offerings
  • SWOT
• 15.14 KROMATID
  • KROMATID - Overview
  • KROMATID - Product / Service
  • KROMATID - Key offerings
  • SWOT
• 15.15 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.16 Pairwise
  • Pairwise - Overview
  • Pairwise - Product / Service
  • Pairwise - Key offerings
  • SWOT
• 15.17 PerkinElmer US LLC
  • PerkinElmer US LLC - Overview
  • PerkinElmer US LLC - Business segments
  • PerkinElmer US LLC - Key offerings
  • PerkinElmer US LLC - Segment focus
  • SWOT
• 15.18 ShapeTX
  • ShapeTX - Overview
  • ShapeTX - Product / Service
  • ShapeTX - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations